KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Current Liabilities (2016 - 2026)

Abbott Laboratories' Total Current Liabilities history spans 18 years, with the latest figure at $18.4 billion for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 41.32% to $18.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $18.4 billion, a 41.32% increase, with the full-year FY2025 number at $16.5 billion, up 16.52% from a year prior.
  • Total Current Liabilities hit $18.4 billion in Q1 2026 for Abbott Laboratories, up from $16.5 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for ABT hit a ceiling of $18.4 billion in Q1 2026 and a floor of $12.4 billion in Q2 2022.
  • Historically, Total Current Liabilities has averaged $14.3 billion across 5 years, with a median of $14.0 billion in 2024.
  • Biggest five-year swings in Total Current Liabilities: decreased 10.64% in 2023 and later soared 41.32% in 2026.
  • Tracing ABT's Total Current Liabilities over 5 years: stood at $15.5 billion in 2022, then decreased by 10.64% to $13.8 billion in 2023, then rose by 2.28% to $14.2 billion in 2024, then grew by 16.52% to $16.5 billion in 2025, then rose by 11.4% to $18.4 billion in 2026.
  • Business Quant data shows Total Current Liabilities for ABT at $18.4 billion in Q1 2026, $16.5 billion in Q4 2025, and $14.6 billion in Q3 2025.